Management of the Incidental Renal Mass

Despite substantial advances in the imaging-based diagnosis of renal masses, the increased detection of incidental renal masses with cross-sectional imaging poses problems to the radiologist and referring physician. Most incidental renal masses can be diagnosed with confidence and either ignored or treated without further testing. However, some renal masses, particularly small ones, remain indeterminate and require a management strategy that is both medically appropriate and practical. In this article, the literature will be reviewed and an approach to the diagnosis and management of the incidental renal mass will be suggested. Management recommendations, derived from data regarding the probability of malignancy in cystic and solid renal masses, are provided for two types of patients, those in the general population and those with limited life expectancy or co-morbidity. The Bosniak classification is used to guide the management of cystic masses, with observation reserved for selected patients, and the presumption of benignity recommended for simple-appearing cystic masses smaller than 1 cm. Among solid renal masses, a more aggressive overall approach is taken. However, additional imaging, and in selected patients, percutaneous biopsy, is recommended to diagnose benign neoplasms. Although additional studies are needed to establish risks and benefits, observation of solid masses may be considered in selected patients. Minimally invasive treatments of renal cancer (including percutaneous ablation) show promise but at the same time challenge the radiologist to review the approach to the incidental renal mass.

© RSNA, 2008

References

  • 1 Kissane JM. Congenital malformations. In: Hepinstall RH, ed. Pathology of the kidney. Boston, Mass: Little, Brown, 1974; 69–119.
  • 2 Tada S, Yamagishi J, Kobayashi H, Hata Y, Kobari T. The incidence of simple renal cyst by computed tomography. Clin Radiol 1983; 34: 437–439.
  • 3 Bosniak MA. The small (less than or equal to 3.0 cm) renal parenchymal tumor: detection, diagnosis, and controversies. Radiology 1991; 179: 307–317.
  • 4 Stone JH. Incidentalomas: clinical correlation and translational science required. N Engl J Med 2006; 354: 2748–2749.
  • 5 Israel GM, Bosniak MA. How I do it: evaluating renal masses. Radiology 2005; 236: 441–450.
  • 6 Rigsby CM, Rosenfield AT, Glickman MG, Hodson J. Hemorrhagic focal bacterial nephritis: findings on gray-scale sonography and CT. AJR Am J Roentgenol 1986; 146: 1173–1177.
  • 7 Jayson M, Sanders H. Increased incidence of serendipitously discovered renal cell carcinoma. Urology 1998; 51: 203–205.
  • 8 Konnak JW, Grossman HB. Renal cell carcinoma as an incidental finding. J Urol 1985; 134: 1094–1096.
  • 9 Luciani LG, Cestari R, Tallarigo C. Incidental renal cell carcinoma-age and stage characterization and clinical implications: study of 1092 patients (1982–1997). Urology 2000; 56: 58–62.
  • 10 Rodriguez-Rubio FI, Diez-Caballero F, Martin-Marquina A, Abad JI, Berian JM. Incidentally detected renal cell carcinoma. Br J Urol 1996; 78: 29–32.
  • 11 Bosniak MA. The current radiological approach to renal cysts. Radiology 1986; 158: 1–10.
  • 12 Bae KT, Heiken JP, Siegel CL, Bennett HF. Renal cysts: is attenuation artifactually increased on contrast-enhanced CT images? Radiology 2000; 216: 792–796.
  • 13 Birnbaum BA, Hindman N, Lee J, Babb JS. Multi-detector row CT attenuation measurements: assessment of intra- and interscanner variability with an anthropomorphic body CT phantom. Radiology 2007; 242: 109–119.
  • 14 Birnbaum BA, Hindman N, Lee J, Babb JS. Renal cyst pseudoenhancement: influence of multidetector CT reconstruction algorithm and scanner type in phantom model. Radiology 2007; 244: 767–775.
  • 15 Maki DD, Birnbaum BA, Chakraborty DP, Jacobs JE, Carvalho BM, Herman GT. Renal cyst pseudoenhancement: beam-hardening effects on CT numbers. Radiology 1999; 213: 468–472.
  • 16 Bosniak MA. Diagnosis and management of patients with complicated cystic lesions of the kidney. AJR Am J Roentgenol 1997; 169: 819–821.
  • 17 Israel GM, Bosniak MA. Follow-up CT of moderately complex cystic lesions of the kidney (Bosniak category IIF). AJR Am J Roentgenol 2003; 181: 627–633.
  • 18 Bosniak MA. Problematic renal masses. In: McClennan BL, ed. Syllabus: a categorical course in genitourinary radiology. Oak Brook, Ill: Radiological Society of North America, 1994; 183–191.
  • 19 Hartman DS, Weatherby E 3rd, Laskin WB, Brody JM, Corse W, Baluch JD. Cystic renal cell carcinoma: CT findings simulating a benign hyperdense cyst. AJR Am J Roentgenol 1992; 159: 1235–1237.
  • 20 Jonisch AI, Rubinowitz A, Mutalik P, Israel G. Can high attenuatin renal cysts be differentiated from renal cell carcinoma at unenhanced computed tomography? Radiology 2007; 243: 445–450.
  • 21 Chung EP, Herts BR, Linnell G, et al. Analysis of changes in attenuation of proven renal cysts on different scanning phases of triphasic MDCT. AJR Am J Roentgenol 2004; 182: 405–410.
  • 22 Siegel CL, McFarland EG, Brink JA, Fisher AJ, Humphrey P, Heiken JP. CT of cystic renal masses: analysis of diagnostic performance and interobserver variation. AJR Am J Roentgenol 1997; 169: 813–818.
  • 23 Spaliviero M, Herts BR, Magi-Galluzzi C, et al. Laparoscopic partial nephrectomy for cystic masses. J Urol 2005; 174: 614–619.
  • 24 Israel GM, Bosniak MA. Calcification in cystic renal masses: is it important in diagnosis? Radiology 2003; 226: 47–52.
  • 25 Volpe A, Panzarella T, Rendon RA, Haider MA, Kondylis FI, Jewett MA. The natural history of incidentally detected small renal masses. Cancer 2004; 100: 738–745.
  • 26 Bosniak MA, Birnbaum BA, Krinsky GA, Waisman J. Small renal parenchymal neoplasms: further observations on growth. Radiology 1995; 197: 589–597.
  • 27 Kassouf W, Aprikian AG, Laplante M, Tanguay S. Natural history of renal masses followed expectantly. J Urol 2004; 171: 111–113.
  • 28 Kunkle DA, Crispen PL, Chen DY, Greenberg RE, Uzzo RG. Enhancing renal masses with zero net growth during active surveillance. J Urol 2007; 177: 849–853.
  • 29 Wehle MJ, Thiel DD, Petrou SP, Young PR, Frank I, Karsteadt N. Conservative management of incidental contrast-enhancing renal masses as safe alternative to invasive therapy. Urology 2004; 64: 49–52.
  • 30 Curry NS, Cochran ST, Bissada NK. Cystic renal masses: accurate Bosniak classification requires adequate renal CT. AJR Am J Roentgenol 2000; 175: 339–342.
  • 31 Koga S, Nishikido M, Inuzuka S, et al. An evaluation of Bosniak's radiological classification of cystic renal masses. BJU Int 2000; 86: 607–609.
  • 32 Aronson S, Frazier HA, Baluch JD, Hartman DS, Christenson PJ. Cystic renal masses: usefulness of the Bosniak classification. Urol Radiol 1991; 13: 83–90.
  • 33 Lang EK. Renal cyst puncture studies. Urol Clin North Am 1987; 14: 91–102.
  • 34 Bosniak MA. Should we biopsy complex cystic renal masses (Bosniak category III)? AJR Am J Roentgenol 2003; 181: 1425–1426.
  • 35 Harisinghani MG, Maher MM, Gervais DA, et al. Incidence of malignancy in complex cystic renal masses (Bosniak category III): should imaging-guided biopsy precede surgery? AJR Am J Roentgenol 2003; 180: 755–758.
  • 36 Silverman SG, Gan YU, Mortele KJ, Tuncali K, Cibas ES. Renal masses in the adult patient: the role of percutaneous biopsy. Radiology 2006; 240: 6–22.
  • 37 Jinzaki M, McTavish JD, Zou KH, Judy PF, Silverman SG. Evaluation of small (</= 3 cm) renal masses with MDCT: benefits of thin overlapping reconstructions. AJR Am J Roentgenol 2004; 183: 223–228.
  • 38 Bosniak MA, Rofsky NM. Problems in the detection and characterization of small renal masses. Radiology 1996; 198: 638–641.
  • 39 Bracken RB, Chica G, Johnson DE, Luna M. Secondary renal neoplasms: an autopsy study. South Med J 1979; 72: 806–807.
  • 40 Mitnick JS, Bosniak MA, Rothberg M, Megibow AJ, Raghavendra BN, Subramanyam BR. Metastatic neoplasm to the kidney studied by computed tomography and sonography. J Comput Assist Tomogr 1985; 9: 43–49.
  • 41 Rybicki FJ, Shu KM, Cibas ES, Fielding JR, vanSonnenberg E, Silverman SG. Percutaneous biopsy of renal masses: sensitivity and negative predictive value stratified by clinical setting and size of masses. AJR Am J Roentgenol 2003; 180: 1281–1287.
  • 42 Choyke PL, Glenn GM, Walther MM, Zbar B, Linehan WM. Hereditary renal cancers. Radiology 2003; 226: 33–46.
  • 43 Linehan WM, Vasselli J, Srinivasan R, et al. Genetic basis of cancer of the kidney: disease-specific approaches to therapy. Clin Cancer Res 2004; 10(18 pt 2): 6282S–6289S.
  • 44 Tickoo SK, Reuter VE, Amin MB, et al. Renal oncocytosis: a morphologic study of fourteen cases. Am J Surg Pathol 1999; 23: 1094–1101.
  • 45 Silverman SG, Gan YU, Mortele KJ, Tuncali K, Cibas ES. Renal mass biopsy in the new millennium: an important diagnostic procedure. In: Ramchandani P, ed. Syllabus: categorical course in diagnostic radiology—genitourinary radiology. Oak Brook, Ill: Radiological Society of North America, 2006; 219–236.
  • 46 Silverman SG, Mortele KJ, Tuncali K, Jinzaki M, Cibas ES. Hyperattenuating renal masses: etiologies, pathogenesis, and imaging evaluation. RadioGraphics 2007; 27: 1131–1143.
  • 47 Birnbaum BA, Bosniak MA, Megibow AJ, Lubat E, Gordon RB. Observations on the growth of renal neoplasms. Radiology 1990; 176: 695–701.
  • 48 Cohen HT, McGovern FJ. Renal-cell carcinoma. N Engl J Med 2005; 353: 2477–2490.
  • 49 Bosniak MA, Megibow AJ, Hulnick DH, Horii S, Raghavendra BN. CT diagnosis of renal angiomyolipoma: the importance of detecting small amounts of fat. AJR Am J Roentgenol 1988; 151: 497–501.
  • 50 Castoldi MC, Dellafiore L, Renne G, Schiaffino E, Casolo F. CT demonstration of liquid intratumoral fat layering in a necrotic renal cell carcinoma. Abdom Imaging 1995; 20: 483–485.
  • 51 Helenon O, Chretien Y, Paraf F, Melki P, Denys A, Moreau JF. Renal cell carcinoma containing fat: demonstration with CT. Radiology 1993; 188: 429–430.
  • 52 Lesavre A, Correas JM, Merran S, Grenier N, Vieillefond A, Helenon O. CT of papillary renal cell carcinomas with cholesterol necrosis mimicking angiomyolipomas. AJR Am J Roentgenol 2003; 181: 143–145.
  • 53 Strotzer M, Lehner KB, Becker K. Detection of fat in a renal cell carcinoma mimicking angiomyolipoma. Radiology 1993; 188: 427–428.
  • 54 Schuster TG, Ferguson MR, Baker DE, Schaldenbrand JD, Solomon MH. Papillary renal cell carcinoma containing fat without calcification mimicking angiomyolipoma on CT. AJR Am J Roentgenol 2004; 183: 1402–1404.
  • 55 Israel GM, Hindman N, Hecht E, Krinsky G. The use of opposed-phase chemical shift MRI in the diagnosis of renal angiomyolipomas. AJR Am J Roentgenol 2005; 184: 1868–1872.
  • 56 Outwater EK, Bhatia M, Siegelman ES, Burke MA, Mitchell DG. Lipid in renal clear cell carcinoma: detection on opposed-phase gradient-echo MR images. Radiology 1997; 205: 103–107.
  • 57 Jinzaki M, Tanimoto A, Narimatsu Y, et al. Angiomyolipoma: imaging findings in lesions with minimal fat. Radiology 1997; 205: 497–502.
  • 58 Kim JK, Park SY, Shon JH, Cho KS. Angiomyolipoma with minimal fat: differentiation from renal cell carcinoma at biphasic helical CT. Radiology 2004; 230: 677–684.
  • 59 Sant GR, Ayers DK, Bankoff MS, Mitcheson HD, Ucci AA Jr. Fine needle aspiration biopsy in the diagnosis of renal angiomyolipoma. J Urol 1990; 143: 999–1001.
  • 60 Hosokawa Y, Kinouchi T, Sawai Y, et al. Renal angiomyolipoma with minimal fat. Int J Clin Oncol 2002; 7: 120–123.
  • 61 Amendola MA, Bree RL, Pollack HM, et al. Small renal cell carcinomas: resolving a diagnostic dilemma. Radiology 1988; 166: 637–641.
  • 62 Shinmoto H, Yuasa Y, Tanimoto A, et al. Small renal cell carcinoma: MRI with pathologic correlation. J Magn Reson Imaging 1998; 8: 690–694.
  • 63 Yamashita Y, Honda S, Nishiharu T, Urata J, Takahashi M. Detection of pseudocapsule of renal cell carcinoma with MR imaging and CT. AJR Am J Roentgenol 1996; 166: 1151–1155.
  • 64 Yoshimitsu K, Kakihara D, Irie H, et al. Papillary renal carcinoma: diagnostic approach by chemical shift gradient-echo and echo-planar MR imaging. J Magn Reson Imaging 2006; 23: 339–344.
  • 65 Sussman SK, Glickstein MF, Krzymowski GA. Hypointense renal cell carcinoma: MR imaging with pathologic correlation. Radiology 1990; 177: 495–497.
  • 66 Fielding JR, Visweswaran A, Silverman SG, Granter SR, Renshaw AA. CT and ultrasound features of metanephric adenoma in adults with pathologic correlation. J Comput Assist Tomogr 1999; 23: 441–444.
  • 67 Jinzaki M, Tanimoto A, Mukai M, et al. Double-phase helical CT of small renal parenchymal neoplasms: correlation with pathologic findings and tumor angiogenesis. J Comput Assist Tomogr 2000; 24: 835–842.
  • 68 Chao DH, Zisman A, Pantuck AJ, Freedland SJ, Said JW, Belldegrun AS. Changing concepts in the management of renal oncocytoma. Urology 2002; 59: 635–642.
  • 69 Liu J, Fanning CV. Can renal oncocytomas be distinguished from renal cell carcinoma on fine-needle aspiration specimens? a study of conventional smears in conjunction with ancillary studies. Cancer 2001; 93: 390–397.
  • 70 Tuncali K, vanSonnenberg E, Shankar S, Mortele KJ, Cibas ES, Silverman SG. Evaluation of patients referred for percutaneous ablation of renal tumors: importance of a preprocedural diagnosis. AJR Am J Roentgenol 2004; 183: 575–582.
  • 71 Frank I, Blute ML, Cheville JC, Lohse CM, Weaver AL, Zincke H. Solid renal tumors: an analysis of pathological features related to tumor size. J Urol 2003; 170: 2217–2220.
  • 72 Kato M, Suzuki T, Suzuki Y, Terasawa Y, Sasano H, Arai Y. Natural history of small renal cell carcinoma: evaluation of growth rate, histological grade, cell proliferation and apoptosis. J Urol 2004; 172: 863–866.
  • 73 Lamb GW, Bromwich EJ, Vasey P, Aitchison M. Management of renal masses in patients medically unsuitable for nephrectomy: natural history, complications, and outcome. Urology 2004; 64: 909–913.
  • 74 Sowery RD, Siemens DR. Growth characteristics of renal cortical tumors in patients managed by watchful waiting. Can J Urol 2004; 11: 2407–2410.
  • 75 Chow WH, Devesa SS, Warren JL, Fraumeni JF Jr. Rising incidence of renal cell cancer in the United States. JAMA 1999; 281: 1628–1631.
  • 76 Homma Y, Kawabe K, Kitamura T, et al. Increased incidental detection and reduced mortality in renal cancer: recent retrospective analysis at eight institutions. Int J Urol 1995; 2: 77–80.
  • 77 Rendon RA, Stanietzky N, Panzarella T, et al. The natural history of small renal masses. J Urol 2000; 164: 1143–1147.
  • 78 Remzi M, Ozsoy M, Klingler HC, et al. Are small renal tumors harmless? analysis of histopathological features according to tumors 4 cm or less in diameter. J Urol 2006; 176: 896–899.
  • 79 Chawla SN, Crispen PL, Hanlon AL, Greenberg RE, Chen DY, Uzzo RG. The natural history of observed enhancing renal masses: meta-analysis and review of the world literature. J Urol 2006; 175: 425–431.
  • 80 Hsu RM, Chan DY, Siegelman SS. Small renal cell carcinomas: correlation of size with tumor stage, nuclear grade, and histologic subtype. AJR Am J Roentgenol 2004; 182: 551–557.
  • 81 Oda T, Miyao N, Takahashi A, et al. Growth rates of primary and metastatic lesions of renal cell carcinoma. Int J Urol 2001; 8: 473–477.
  • 82 Hollingsworth JM, Miller DC, Daignault S, Hollenbeck BK. Rising incidence of small renal masses: a need to reassess treatment effect. J Natl Cancer Inst 2006; 98: 1331–1334.
  • 83 Nascimento AB, Mitchell DG, Zhang XM, Kamishima T, Parker L, Holland GA. Rapid MR imaging detection of renal cysts: age-based standards. Radiology 2001; 221: 628–632.
  • 84 Israel GM, Hindman N, Bosniak MA. Evaluation of cystic renal masses: comparison of CT and MR imaging by using the Bosniak classification system. Radiology 2004; 231: 365–371.
  • 85 Rofsky NM, Weinreb JC, Bosniak MA, Libes RB, Birnbaum BA. Renal lesion characterization with gadolinium-enhanced MR imaging: efficacy and safety in patients with renal insufficiency. Radiology 1991; 180: 85–89.
  • 86 Grobner T. Gadolinium: a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis? Nephrol Dial Transplant 2006; 21: 1104–1108.
  • 87 Cova M, Squillaci E, Stacul F, et al. Diffusion-weighted MRI in the evaluation of renal lesions: preliminary results. Br J Radiol 2004; 77: 851–857.
  • 88 de Baere T, Kuoch V, Smayra T, et al. Radio frequency ablation of renal cell carcinoma: preliminary clinical experience. J Urol 2002; 167: 1961–1964.
  • 89 Gervais DA, McGovern FJ, Wood BJ, Goldberg SN, McDougal WS, Mueller PR. Radio-frequency ablation of renal cell carcinoma: early clinical experience. Radiology 2000; 217: 665–672.
  • 90 Gervais DA, McGovern FJ, Arellano RS, McDougal WS, Mueller PR. Renal cell carcinoma: clinical experience and technical success with radio-frequency ablation of 42 tumors. Radiology 2003; 226: 417–424.
  • 91 Hui GC, Zu K, Tuncali K, Tatli S, Morrison PR, Silverman SG. Comparison of percutaneous and surgical approaches to renal tumor ablation: meta-analysis of effectiveness and complication rates. JVIR (in press).
  • 92 Mayo-Smith WW, Dupuy DE, Parikh PM, Pezzullo JA, Cronan JJ. Imaging-guided percutaneous radiofrequency ablation of solid renal masses: techniques and outcomes of 38 treatment sessions in 32 consecutive patients. AJR Am J Roentgenol 2003; 180: 1503–1508.
  • 93 Pavlovich CP, Walther MM, Choyke PL, et al. Percutaneous radio frequency ablation of small renal tumors: initial results. J Urol 2002; 167: 10–15.
  • 94 Roy-Choudhury SH, Cast JE, Cooksey G, Puri S, Breen DJ. Early experience with percutaneous radiofrequency ablation of small solid renal masses. AJR Am J Roentgenol 2003; 180: 1055–1061.
  • 95 Shingleton WB, Sewell PE Jr. Percutaneous renal tumor cryoablation with magnetic resonance imaging guidance. J Urol 2001; 165: 773–776.
  • 96 Shingleton WB, Sewell PE Jr. Percutaneous renal cryoablation of renal tumors in patients with von Hippel-Lindau disease. J Urol 2002; 167: 1268–1270.
  • 97 Silverman SG, Tuncali K, vanSonnenberg E, et al. Renal tumors: MR imaging-guided percutaneous cryotherapy—initial experience in 23 patients. Radiology 2005; 236: 716–724.
  • 98 Uchida M, Imaide Y, Sugimoto K, Uehara H, Watanabe H. Percutaneous cryosurgery for renal tumours. Br J Urol 1995; 75: 132–136.
  • 99 Wills JS. Management of small renal neoplasms and angiomyolipoma: a growing problem. Radiology 1995; 197: 583–586.
  • 100 Black WC, Ling A. Is earlier diagnosis really better? The misleading effects of lead time and length biases. AJR Am J Roentgenol 1990; 155: 625–630.
  • 101 Francis IR, Choyke P, Bluth E, et al. Indeterminate renal masses. ACR Appropriateness Criteria, Summary of Literature Review. Reston, Va: American College of Radiology, 2005.
  • 102 Berlin L. Failure to diagnose lung cancer: anatomy of a malpractice trial. AJR Am J Roentgenol 2003; 180: 37–45.

Article History

Published in print: 2008